Philips will halt sales of its bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) machines under a tentative agreement it reached with the U.S. Food and Drug ...

Philips has reached a $1.1 billion agreement to settle claims from about 58,000 people stemming from its yearslong recall of home CPAP ventilators and sleep apnea machines. It’s a major milestone in ...

Earlier this week, the U.S. Department of Justice, representing the Food and Drug Administration and healthcare technology company Philips came to an agreement to no longer sell their sleep therapy or ...

Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

In 2021, polyester-based polyurethane (PE-PUR) foam used in Philips Respironics ventilators, CPAP and BiPAP machines was found to degrade and cause serious health issues or death, leading to a mass ...

FROM SHADYSIDE TONIGHT. PHILIPS REIS RUN ROAD RECALLED MILLIONS OF CPAPS BIPAPS AND VENTILATORS AFTER THE FDA SAID FOAM INSULATION INSIDE THOSE MACHINES WAS A HEALTH RISK. BUT IN A LAWSUIT, PHILIPS ...

Three years after one of the largest medical device recalls in history, the fallout – health-wise and financial – continues to impact many patients with sleep apnea. Now a critical deadline is ...